1-4 of 4
Jan Martin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2492: Enhanced patient selection for anti-PD-L1 treatment in metastatic NSCLC with quantitative continuous scoring of PD-L1

Free
Jan Martin Lesniak, Markus Schick, Thomas Kunzke, Federico Pollastri, Juan Pedro Vigueras-Guillén, Harald Hessel, Susanne Haneder, Pallavi Sontakke, Karma DaCosta, Regina Alleze, Hadassah Sade, J Carl Barrett, Günter Schmidt, Ross Stewart
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 2492.
https://doi.org/10.1158/1538-7445.AM2024-2492
Published: 22 March 2024
View article titled, Abstract 2492: Enhanced patient selection for anti-PD-L1 treatment in metastatic NSCLC with quantitative continuous scoring of PD-L1
Journal Articles

Abstract 7617: Quantitative continuous scoring of PD-L1 for superior patient selection for anti-PD-L1 treatment of locally advanced or unresectable NSCLC

Free
Jan Martin Lesniak, Ina Bisha, Simon Christ, Lina Meinecke, Thomas Padel, Laura Sebastian Monasor, Pallavi Sontakke, Tze Heng Tan, Dasa Medrikova, Andrea Storti, Anatoliy Shumilov, Hadassah Sade, Günter Schmidt, Ross Stewart, Yashaswi Shrestha
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 7617.
https://doi.org/10.1158/1538-7445.AM2024-7617
Published: 22 March 2024
View article titled, Abstract 7617: Quantitative continuous scoring of PD-L1 for superior patient selection for anti-PD-L1 treatment of locally advanced or unresectable NSCLC
Journal Articles

In Melanoma, RAS Mutations Are Accompanied by Switching Signaling from BRAF to CRAF and Disrupted Cyclic AMP Signaling

Free
Nicolas Dumaz, Robert Hayward, Jan Martin, Lesley Ogilvie, Douglas Hedley, John A. Curtin, Boris C. Bastian, Caroline Springer, Richard Marais
Journal: Cancer Research
Cancer Res (2006) 66 (19): 9483–9491.
https://doi.org/10.1158/0008-5472.CAN-05-4227
Published: 03 October 2006
View article titled, In Melanoma, RAS Mutations Are Accompanied by Switching Signaling from BRAF to CRAF and Disrupted Cyclic AMP Signaling
Open the PDF for In Melanoma, RAS Mutations Are Accompanied by Switching Signaling from BRAF to CRAF and Disrupted Cyclic AMP Signaling in another window
Includes: Supplementary data
Journal Articles

V599EB-RAF is an Oncogene in Melanocytes

Free
Claudia Wellbrock, Lesley Ogilvie, Douglas Hedley, Maria Karasarides, Jan Martin, Dan Niculescu-Duvaz, Caroline J. Springer, Richard Marais
Journal: Cancer Research
Cancer Res (2004) 64 (7): 2338–2342.
https://doi.org/10.1158/0008-5472.CAN-03-3433
Published: 01 April 2004
View article titled, V599EB-RAF is an Oncogene in Melanocytes
Open the PDF for V599EB-RAF is an Oncogene in Melanocytes in another window